• <progress id="6akbd"></progress><li id="6akbd"></li>
      <track id="6akbd"><option id="6akbd"></option></track>
      <noframes id="6akbd">

      <progress id="6akbd"><tbody id="6akbd"></tbody></progress>
      Products
      Products
      < Back
      JC200

      Model JC200 Focused Ultrasound Tumor Therapeutic System

      Non-invasive, extracorporeal ultrasound ablation treatment of tumors


      Download the brochure of JC200

      Indications

      Solid tumors of all types of soft tissues such as:

      Benign:

      Benign gynecologic tumors such as uterine fibroids

      Malignant:

      ? liver tumors
      ? bone tumors
      ? breast tumors
      ? fibroadenoma of breast


      Contraindications
      ?  Tumor of head 
      ?  Tumor in spine and vertebral canal 
      ?  Tumor of gastrointestinal tract
      ?  Tumor in thoracic cavity 
      ?  Tumor of hollow viscous with obstruction


      Clinical Advangtages
      ? Noninvasive treatment to preserve organs and structures, with no blood transfusion and no radiation
      ? Conformal and precise ablation
      ? One time treatment, no limitation by tumor size and shape
      ? Real-time ultrasound-guided therapy with digital quantitative analysis
      ? Activation of immune system


      Approvals: Europe: CE, China: CFDA



      Package Price: three million and two hundred thousand US dollars ($3,200,000) to three million and nine hundred thousand US dollars ($3,900,000), including: 

      1. The commodity of Model JC200 Focused Ultrasound Tumor Therapeutic System
      2. HIFU doctor training
      3. On-site clinical support
      4. One (1) to five (5) years of guarantee and maintenance of the commodity
      5. One (1) to five (5) years of clinical service via telemedicine center
      6. One (1) to five (5) years of engineering service via telemedicine center
      7. Five (5) years of software upgrade
      女人国产香樵久久精品